Get the Stockscreener App
2.59
4.43%
-0.12
After Hours:
2.54
-0.05
-1.93%
Aclarion Inc stock is traded at $2.59, with a volume of 32,761.
It is down -4.43% in the last 24 hours and down -42.57% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$2.71
Open:
$2.68
24h Volume:
32,761
Relative Volume:
0.04
Market Cap:
$2.73M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.2849
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
+9.75%
1M Performance:
-42.57%
6M Performance:
-64.42%
1Y Performance:
-97.95%
1-Day Range:
$2.50
$2.70
1-Week Range:
$2.41
$2.85
52-Week Range:
$2.3401
$229.50
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, TEM, BTSG, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.59 | 2.86M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
171.99 | 29.10B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
50.78 | 9.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
37.79 | 7.22B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
73.21 | 6.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
24.71 | 4.80B | 550.17M | 201.35M | 232.07M | 1.00 |
Aclarion Inc Stock (ACON) Latest News
NeuroOne Medical Technologies (NASDAQ:NMTC) versus Aclarion (NASDAQ:ACON) Head to Head Contrast - Defense World
How does Aclarion Inc. compare to its peersInsider Selling & Precise Trade Entry Recommendations - mfd.ru
Market Leaders: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Profit Report & Short-Term High Return Ideas - baoquankhu1.vn
Jobs Data: Should I add Motorcar Parts of America Inc stock to my portfolioDip Buying & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Analyst Upgrade: Does SPOT have declining or rising EPSOil Prices & Community Trade Idea Sharing - baoquankhu1.vn
Aclarion secures $10.4M for back-pain diagnostic technology - BizWest
Aclarion Publishes 2026 Shareholder Letter from the Chairman - The Globe and Mail
Aclarion, Inc. Announces Strong Financial Position and Path to CLARITY Trial Milestones Ahead of 2026 - Quiver Quantitative
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes - Asianet Newsable
Aclarion CEO Outlines 2026 Execution Plan Focused on Reimbursement and Adoption - intellectia.ai
Aclarion CEO Bets On Bigger AI MedTech’s Playbook To Revive Sagging Stock - Stocktwits
Aclarion partners with Source Healthcare to expand Nociscan availability By Investing.com - Investing.com Nigeria
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation - Ortho Spine News
Aclarion Expands Nociscan Availability in Greater Los Angeles - Intellectia AI
Aclarion partners with Source Healthcare to expand Nociscan availability - Investing.com
Aclarion Expands Nociscan Availability in Greater Los Angeles Area Through Partnership with Source Healthcare - Quiver Quantitative
LA pain clinic adds Aclarion’s noninvasive alternative to spinal injections - stocktitan.net
Healthcare Stocks To Keep An Eye OnJanuary 8th - MarketBeat
Is Aclarion Inc. Equity Warrant stock suitable for long term investingJuly 2025 Action & Real-Time Sentiment Analysis - mfd.ru
Investment Recap: What is Aclarion Inc Equity Warrants 5 year growth outlookWatch List & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Will Aclarion Inc. Equity Warrant outperform tech stocksCPI Data & Weekly Setup with ROI Potential - mfd.ru
Short Interest in Aclarion, Inc. (NASDAQ:ACON) Rises By 379.3% - Defense World
Investment Review: How do insiders feel about Nova Minerals Limited Depositary ReceiptJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
Aug Reactions: What is Aclarion Inc Equity Warrants 5 year growth outlookJuly 2025 Update & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Growth Report: Will KVUE outperform tech stocks2025 Buyback Activity & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Weekly Trades: Can FNGD ride the EV waveWeekly Stock Recap & Smart Money Movement Tracker - baoquankhu1.vn
S P Trends: Will Aclarion Inc stock recover after earningsWeekly Stock Report & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Aclarion to enroll around 25% of patients in CLARITY trial by Q2 - MSN
Earnings Update: Is Aclarion Inc Equity Warrant stock undervalued right nowBear Alert & Free Reliable Trade Execution Plans - baoquankhu1.vn
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World
Levels Update: Can FENC scale operations efficientlyWeekly Volume Report & Real-Time Buy Zone Alerts - baoquankhu1.vn
Pharma News: Is Perpetua Resources Corp forming a bullish divergenceWeekly Trading Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Decliners Report: Will Aclarion Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
Is the Market Bullish or Bearish on Aclarion Inc? - Sahm
Aclarion raises $10.4 million to fund chronic back pain technology By Investing.com - Investing.com Nigeria
Risk Check: Will Aclarion Inc stock gain from government policiesProfit Target & Daily Profit Focused Stock Screening - Bộ Nội Vụ
Aug Update: What are Aclarion Incs earnings expectations2025 Performance Recap & Daily Profit Maximizing Tips - baoquankhu1.vn
Med-tech startup Aclarion raises $10.4M in stock sale - BizWest
What's Going On With Aclarion Stock Tuesday?Aclarion (NASDAQ:ACON) - Benzinga
Profit Recap: Why Aclarion Inc. stock appeals to dividend seekers2025 Technical Patterns & Accurate Buy Signal Alerts - Bộ Nội Vụ
Aclarion Incextends cash runway into 2028SEC filing - marketscreener.com
Aclarion Strengthens Balance Sheet With New Equity Financing - TipRanks
Aclarion, Inc. Closes $10.4 Million Financing to Extend Cash Runway - TradingView
Aclarion raises $10.4 million to fund chronic back pain technology - Investing.com
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028 - The Manila Times
Aclarion, Inc. Secures $10.4 Million in Common-Stock Financing to Strengthen Balance Sheet and Extend Operating Runway - Quiver Quantitative
Published on: 2026-01-13 07:30:48 - Улправда
Aclarion Announces $10.4 Million Registered Direct Offering - The Globe and Mail
Healthcare Stocks To Keep An Eye On – January 8th - Defense World
How Aclarion Inc. stock reacts to global recession fearsJuly 2025 Intraday Action & Accurate Intraday Trade Tips - Улправда
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
16.55%
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):